ClinicalTrials.gov
ClinicalTrials.gov Menu

Characteristics of Treatment Responders to Galantamine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01029132
Recruitment Status : Completed
First Posted : December 9, 2009
Last Update Posted : January 6, 2016
Sponsor:
Collaborator:
Janssen Korea, Ltd., Korea
Information provided by (Responsible Party):
Doh Kwan Kim, Samsung Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2009
  Actual Study Completion Date : October 2009